- Faron confirms plans under new leadership
- Appointment of Chief Financial Officer
- Approval of Warrant Terms and Conditions
- Decisions of the Board of Directors
- Appointment of Chief Executive Officer
- Results of the Annual General Meeting
- Announcement of Placing
- Issue of Warrants to IPF Funding Update
- Faron´s Annual Report 2023
- Additional Positive Data from Phase 1 of BEXMAB
More ▼
Key statistics
As of last trade, Faron Pharmaceuticals Oy (FARN:LSE) traded at 135.00, 19.47% above the 52 week low of 113.00 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 127.50 |
---|---|
High | 113.00 |
Low | 113.00 |
Bid | 120.00 |
Offer | 135.00 |
Previous close | 127.50 |
Average volume | 18.67k |
---|---|
Shares outstanding | 72.01m |
Free float | 43.33m |
P/E (TTM) | -- |
Market cap | 91.70m GBP |
EPS (TTM) | -0.4068 GBP |
Data delayed at least 20 minutes, as of Apr 26 2024 10:12 BST.
More ▼